Last reviewed · How we verify
NCT05830318
Usability and Acceptability Study of the P-STEP Mobile Application
trial testing P-STEP Mobile Application in Asthma in 380 participants. Status unknown.
22 December 2023
Quick facts
| Lead sponsor | University of Leicester |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 380 |
| Start date | 23 August 2023 |
| Primary completion | 22 December 2023 |
| Estimated completion | 31 January 2024 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- P-STEP Mobile Application
Conditions studied
- Asthma — all drugs for Asthma →
- Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →
- Interstitial Lung Disease — all drugs for Interstitial Lung Disease →
- Coronary Heart Disease — all drugs for Coronary Heart Disease →
Sponsor
University of Leicester
Who can join
Adults 18 to 99, any sex, with Asthma or Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Assess the usability and acceptance of the P-STEP app, through allowing participants with specific chronic conditions to pilot the app for 12-weeks.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Evaluation of the usability and acceptability of the P-STEP® mobile app: feasibility study protocol.
Worboys H, Gray L, Anthony S, Hobson R, et al · · 2024 · cited 3× · PMID 39272125 · DOI 10.1186/s40814-024-01546-9 -
A feasibility study evaluating the usability and acceptability of the personalised space technology exercise platform mobile application.
Worboys HM, Gray LJ, Anthony S, Hobson R, et al · · 2025 · cited 1× · PMID 41107355 · DOI 10.1038/s41598-025-20314-0 -
Evaluation of the usability and acceptability of the P-STEP (Personalised Space Technology Exercise Platform) ® mobile app: Feasibility study
Worboys H, Gray LJ, Anthony S, Hobson R, et al · · 2025 · DOI 10.21203/rs.3.rs-6123032/v1
Verify or expand the search:
- PubMed search for NCT05830318
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Asthma
Currently open trials in the same condition.
- NCT07525375 — A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t · Phase 2 · recruiting
- NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
- NCT07556159 — A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice · recruiting
- NCT07282886 — VENTURI (VENTilation Using Respiratory Imaging) · Phase 2 · recruiting
- NCT07433569 — A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Differ · Phase 1 · recruiting
Other University of Leicester trials
Trials by the same sponsor.
- NCT07389785 — Age Related Chromatin Remodelling as a Therapeutic Target for Organ Protection in Cardiac Surgery · active not recruiting
- NCT07014579 — Using Heart Electrical Signals to Study How Well Treatments Prevent Dangerous Heart Rhythms in Active People · not yet recruiting
- NCT06955663 — Exercise Support and Rehabilitation for Patients After Spontaneous Coronary Artery Dissection · NA · recruiting
- NCT06629675 — Make Every Step Count: Personalised Music Feedback to Walking for People Living With COPD · NA · recruiting
- NCT06844656 — Understanding the Increased Risk of Atrial Fibrillation in Athletes: a Case-control Study · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05830318 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Leicester
- Last refreshed: 20 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05830318.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing